DaVita plays down Ozempic’s potential in treating kidney disease
October 12, 2023 at 12:42 PM EDT
Dialysis company DaVita is not convinced a Novo Nordisk trial's findings relating to its Ozempic treatment will be borne out over time.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|